Cl2A-SN-38
CAS: 1279680-68-0
Ref. 3D-EBC68068
1mg | 172,00 € | ||
2mg | 279,00 € | ||
5mg | 364,00 € | ||
10mg | 518,00 € | ||
25mg | 801,00 € |
Información del producto
Cl2A-SN-38 is a novel anticancer drug that has demonstrated significant antitumor activity in preclinical animal models of lymphocytic leukemia. Cl2A-SN-38 is a bioconjugate composed of the chemotherapeutic agent SN-38 and the monoclonal antibody Cl2A. The Cl2A binds to tumor cells and targets them for destruction by the SN-38, which is released from the conjugate and enters into the cell through receptor mediated endocytosis. The drug has been shown to have synergistic effects when combined with radiation or other chemotherapy drugs. It has also been shown to induce apoptotic signaling in tumor cells, leading to cell death without affecting normal tissue.
Propiedades químicas
Consulta técnica sobre: 3D-EBC68068 Cl2A-SN-38
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.